Mir Gets Two-Year Ban From USADA

Former UFC heavyweight champion Frank Mir may want out of the UFC, but he isn’t going to be competing for a while regardless.

Mir has been suspended two years by USADA for an anti-doping violation. The UFC officially announced the suspension on Friday. After a loss to Mark Hunt at a UFC Fight Night back in March 2016, an in-competition sample revealed that Mir tested positive for a long-term metabolite of dehydrochloromethyltestosterone (DHCMT).

The suspension is backdated to April 8, 2016, meaning Mir will be ineligible to return to active competition for approximately one more year.

"DHCMT is a non-Specified Substance in the class of Anabolic Agents and prohibited at all times under the UFC Anti-Doping Policy, which has adopted the World Anti-Doping Agency (WADA) Prohibited List," USADA stated in a press release. "The finding of a long-term DHCMT metabolite in Mir’s sample, which was identified through a new detection method by the WADA-accredited laboratory in Tokyo, Japan, led to Mir being provisionally suspended from competition on April 8, 2016.

"Upon learning of the positive results of the sample analyzed in Tokyo, USADA had all previously collected stored samples for Mir reanalyzed at the WADA-accredited laboratory in Salt Lake City, Utah (SMRTL), which had also recently implemented methodology for the detection of newly identified long-term DHCMT metabolites. As a result of the additional analyses, SMRTL discovered that an out-of-competition sample Mir provided on February 5, 2016, which had previously been reported to USADA as negative for the presence of prohibited substances, was also positive for the same long-term DHCMT metabolite found in Mir’s in-competition sample."

Since the news of the positive test sample first broke, Mir has requested his release from the MMA promotion. He has yet to be officially released, however.

Mir has lost six of his last eight MMA fights.

You might also like

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More